Search

Author/Creator Krause, Silva

1. Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma. (June 2020)

Authors:
O'Reilly, Eileen M.; Barone, Diletta; Mahalingam, Devalingam; Bekaii-Saab, Tanios; Shao, Spencer H.; Wolf, Julie; Rosano, Molly; Krause, Silva; Richards, Donald A.; Yu, Kenneth H.; Roach, James M.; Flaherty, Keith T.; Ryan, David P.
Journal:
European journal of cancer
Issue:
Volume 132(2020)
Page Start:
112
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab‐Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results. (4th December 2017)

Authors:
O'Reilly, Eileen M.; Roach, James; Miller, Paul; Yu, Kenneth H.; Tjan, Catherine; Rosano, Molly; Krause, Silva; Avery, William; Wolf, Julie; Flaherty, Keith; Nix, Darrell; Ryan, David P.
Journal:
Oncologist
Issue:
Volume 22:Number 12(2017)
Page Start:
1429
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab‐Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results. (4th December 2017)

Authors:
O'Reilly, Eileen M.; Roach, James; Miller, Paul; Yu, Kenneth H.; Tjan, Catherine; Rosano, Molly; Krause, Silva; Avery, William; Wolf, Julie; Flaherty, Keith; Nix, Darrell; Ryan, David P.
Journal:
Oncologist
Issue:
Volume 22:Number 12(2017)
Page Start:
1429
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search